XML 177 R77.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Method Investments - Summarized Statement of Operations (Details) - USD ($)
$ in Millions
5 Months Ended 7 Months Ended 12 Months Ended
Dec. 31, 2019
Aug. 04, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Equity Method Investment, Summarized Financial Information [Abstract]          
Revenue     $ 245.3 $ 307.5 $ 334.1
Operating expenses     334.8 514.5 491.3
Net income (loss)     (193.0) (317.6) $ (299.1)
Perfomex          
Equity Method Investment, Summarized Financial Information [Abstract]          
Revenue $ 49.8   110.1 134.4  
Operating expenses 47.4   105.0 121.4  
Net income (loss) 1.5   1.0 11.8  
Perfomex II          
Equity Method Investment, Summarized Financial Information [Abstract]          
Revenue 0.0   61.9 45.2  
Operating expenses 0.0   54.2 45.6  
Net income (loss) 0.0   $ 5.1 0.2  
Opex          
Equity Method Investment, Summarized Financial Information [Abstract]          
Revenue 68.1 $ 199.4   263.8  
Operating expenses 85.7 167.7   223.9  
Net income (loss) (19.8) 30.9   10.7  
Akal          
Equity Method Investment, Summarized Financial Information [Abstract]          
Revenue 0.0 102.2   122.4  
Operating expenses 0.0 107.1   123.6  
Net income (loss) $ 0.0 $ (1.7)   $ (3.4)